Your browser is no longer supported. Please, upgrade your browser.
Settings
PFE Pfizer Inc. daily Stock Chart
PFE [NYSE]
Pfizer Inc.
IndexS&P 500 P/E15.54 EPS (ttm)2.46 Insider Own0.04% Shs Outstand5.55B Perf Week0.61%
Market Cap207.99B Forward P/E11.62 EPS next Y3.29 Insider Trans-7.37% Shs Float5.55B Perf Month6.77%
Income13.85B PEG2.90 EPS next Q0.71 Inst Own72.40% Short Float0.81% Perf Quarter1.70%
Sales49.20B P/S4.23 EPS this Y62.30% Inst Trans0.71% Short Ratio1.91 Perf Half Y-0.39%
Book/sh11.58 P/B3.30 EPS next Y12.80% ROA8.30% Target Price41.33 Perf Year4.92%
Cash/sh2.09 P/C18.27 EPS next 5Y5.37% ROE22.00% 52W Range27.88 - 40.97 Perf YTD-2.55%
Dividend1.52 P/FCF45.46 EPS past 5Y14.70% ROI14.70% 52W High-6.81% Beta0.64
Dividend %3.98% Quick Ratio1.20 Sales past 5Y0.90% Gross Margin80.40% 52W Low36.94% ATR0.70
Employees88300 Current Ratio1.40 Sales Q/Q-11.00% Oper. Margin31.10% RSI (14)60.82 Volatility1.77% 1.79%
OptionableYes Debt/Eq0.99 EPS Q/Q-31.50% Profit Margin28.80% Rel Volume1.22 Prev Close37.43
ShortableYes LT Debt/Eq0.79 EarningsOct 27 BMO Payout57.90% Avg Volume23.69M Price38.18
Recom2.60 SMA203.75% SMA503.05% SMA2005.42% Volume28,904,983 Change2.00%
Oct-12-20Downgrade Atlantic Equities Overweight → Neutral $44 → $39
Sep-29-20Initiated Berenberg Hold $38
Jun-16-20Initiated SVB Leerink Mkt Perform $40
Feb-27-20Upgrade Standpoint Research Hold → Buy
Feb-27-20Initiated Barclays Equal Weight $36
Feb-06-20Initiated Mizuho Buy
Jan-07-20Initiated RBC Capital Mkts Outperform $46
Oct-17-19Resumed BofA/Merrill Neutral $37
Jul-30-19Downgrade Morgan Stanley Overweight → Equal-Weight $48 → $40
Jul-30-19Downgrade BofA/Merrill Buy → Neutral
Jun-04-19Resumed Morgan Stanley Overweight $48
Feb-20-19Resumed Citigroup Neutral $41
Jan-31-19Upgrade Credit Suisse Neutral → Outperform
Jan-31-19Upgrade Argus Hold → Buy
Jan-23-19Downgrade UBS Buy → Neutral
Dec-11-18Downgrade JP Morgan Overweight → Neutral
Nov-01-18Downgrade BMO Capital Markets Outperform → Market Perform
Jun-08-18Initiated Cantor Fitzgerald Overweight $45
Apr-05-18Downgrade Barclays Overweight → Equal Weight $41 → $38
Jan-29-18Reiterated SunTrust Hold $33 → $40
Oct-25-20 11:32AM  
06:14AM  
Oct-24-20 02:01PM  
12:35PM  
06:55AM  
06:14AM  
Oct-23-20 07:51PM  
07:17PM  
04:33PM  
03:30PM  
11:33AM  
10:48AM  
10:32AM  
10:16AM  
10:05AM  
09:44AM  
07:28AM  
02:00AM  
Oct-22-20 04:51PM  
04:28PM  
03:34PM  
01:59PM  
01:43PM  
12:44PM  
10:37AM  
10:19AM  
10:15AM  
08:50AM  
08:30AM  
07:20AM  
Oct-21-20 05:31PM  
04:49PM  
04:34PM  
03:41PM  
02:16PM  
12:00PM  
10:45AM  
08:30AM  
Oct-20-20 04:27PM  
03:49PM  
02:46PM  
02:11PM  
01:50PM  
01:26PM  
12:32PM  
12:15PM  
12:02PM  
10:57AM  
10:49AM  
10:24AM  
10:12AM  
10:11AM  
08:47AM  
06:15AM  
Oct-19-20 07:49PM  
05:45PM  
04:32PM  
04:27PM  
10:22AM  
10:00AM  
09:47AM  
02:38AM  
Oct-18-20 10:59PM  
10:04PM  
08:43PM  
12:50PM  
08:12AM  
03:29AM  
Oct-17-20 05:34PM  
07:40AM  
Oct-16-20 05:23PM  
04:57PM  
04:47PM  
04:44PM  
04:28PM  
04:27PM  
04:19PM  
04:01PM  
03:38PM  
03:36PM  
03:29PM  
03:24PM  
02:39PM  
02:37PM  
02:18PM  
02:13PM  
01:45PM  
01:38PM  
01:30PM  
01:26PM  
01:26PM  
01:25PM  
01:16PM  
11:45AM  
11:41AM  
11:17AM  
11:10AM  
10:48AM  
10:47AM  
09:57AM  
Pfizer Inc. develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Sutent, Xtandi, Xalkori, Inlyta, Braftovi + Mektovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Vfend, and Zithromax brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, and tick-borne encephalitis under the Prevnar 13/Prevenar 13 (pediatric/adult), FSME-IMMUN, Nimenrix, and Trumenba brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, Genotropin, and Refacto AF/Xyntha brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration and/or co-promotion agreements with Bristol-Myers Squibb Company and Astellas Pharma US, Inc.; a licensing agreement with Akcea Therapeutics, Inc; a strategic alliance with Verily Life Sciences LLC; collaboration agreements with Merck KGaA and Valneva SE; a clinical trial collaboration and supply agreement with IDEAYA Biosciences, Inc.; a material transfer and collaboration agreement with BioNTech SE; a clinical supply collaboration with Jiangsu Alphamab Biopharmaceuticals Co., Ltd; a research collaboration and license agreement with BioInvent International AB; and a multi-target drug discovery collaboration with Sosei Group Corporation. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BLAYLOCK RONALD EDirectorAug 06Buy38.5513,000501,08513,000Aug 10 08:07 AM
DAMICO JENNIFER B.SVP & ControllerJun 05Sale36.132,18178,8007,542Jun 08 04:29 PM
Dolsten MikaelPresident R&DMay 18Sale37.7895,3533,602,681174,918May 19 05:37 PM
DAMICO JENNIFER B.SVP & ControllerApr 29Sale38.352,18183,6419,647May 01 03:56 PM
JOHNSON RADY AExecutive Vice PresidentApr 29Sale38.3613,125503,47563,940May 01 03:56 PM
ROGERS DAWNExecutive Vice PresidentApr 29Sale38.1313,000495,6904,823May 01 03:56 PM
LANKLER DOUGLAS MExecutive Vice PresidentApr 29Sale37.8565,0002,460,37278,276May 01 03:56 PM
PFIZER INC10% OwnerMar 16Buy16.00312,5005,000,0001,481,719Mar 16 07:15 PM
GOETTLER MICHAELGroup PresidentFeb 28Option Exercise27.3722,852625,45953,036Mar 03 12:54 PM
JOHNSON RADY AExecutive Vice PresidentFeb 28Option Exercise27.3715,996437,81187,956Mar 03 12:54 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 28Option Exercise27.3738,8481,063,270172,542Mar 03 12:54 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentFeb 28Option Exercise27.3737,9341,038,254140,256Mar 03 12:54 PM
ROGERS DAWNExecutive Vice PresidentFeb 28Option Exercise27.3717,824487,84330,045Mar 03 12:54 PM
SUSMAN SALLYExecutive Vice PresidentFeb 28Option Exercise27.3791,4082,501,837222,496Mar 03 12:55 PM
YOUNG JOHN DGroup PresidentFeb 28Option Exercise27.37100,5482,751,999504,427Mar 03 12:55 PM
BOURLA ALBERTChairman & CEOFeb 28Option Exercise27.3733,135906,905232,888Mar 03 12:49 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 28Option Exercise27.3727,422750,540140,744Mar 03 12:49 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 28Option Exercise27.37173,6754,753,485556,084Mar 03 12:49 PM
YOUNG JOHN DGroup PresidentFeb 26Option Exercise34.59144,9285,013,060503,738Feb 28 07:32 PM
ROGERS DAWNExecutive Vice PresidentFeb 26Option Exercise34.5915,097522,20524,995Feb 28 07:28 PM
SUSMAN SALLYExecutive Vice PresidentFeb 26Option Exercise34.5972,4642,506,530180,558Feb 28 07:28 PM
JOHNSON RADY AExecutive Vice PresidentFeb 26Option Exercise34.5933,4141,155,79093,211Feb 28 07:24 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 26Option Exercise34.5988,5673,063,533189,936Feb 28 07:25 PM
GOETTLER MICHAELGroup PresidentFeb 26Option Exercise34.5920,129696,26245,557Feb 28 07:22 PM
Hwang AngelaGroup PresidentFeb 26Option Exercise34.5914,493501,31332,470Feb 28 07:22 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 26Option Exercise34.59144,9285,013,060482,320Feb 28 07:19 PM
BOURLA ALBERTChairman & CEOFeb 26Option Exercise34.5988,5673,063,533274,479Feb 28 07:16 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 26Option Exercise34.5924,155835,521131,196Feb 28 07:15 PM
Gottlieb ScottDirectorJan 30Buy37.001,00036,9974,000Jan 31 08:06 AM
affiliate | advertise | contact | privacy | help
Do not sell my personal information

Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2020 FINVIZ.com. All Rights Reserved.